30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Voyager Therapeutics Inc (VYGR)

Track

Over the last 90 days, Voyager Therapeutics Inc. has seen net insider selling totaling $44,547.57, with executives accounting for this entire amount. There were 4 total transactions, all of which were sales. The company's stock price has decreased by 19.0% in the same period. The last earnings report showed an 11.32% beat.
Stock chart
Ticker: VYGR Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Jorgensen Nathan D.
Former Officer
2 sales — total 136,822 USD
Proposed sale 15 May 2026
Value US$2,209,389.01 | Price 463.15 | Shares 85,450
Proposed sale 15 May 2026
Value US$3,101,619.37 | Price 59.34 | Shares 21,953
Sale 2 Apr 2026
Value US$2,093,026.61 | Price 284.74 | Shares 38,295
Proposed sale 2 Apr 2026
Value US$3,514,193.68 | Price 212.73 | Shares 74,324
Sale 24 Feb 2026
Value US$24,346.66 | Price 3.77 | Shares 6,458
Proposed sale 24 Feb 2026
Value US$24,335.04 | Price 3.77 | Shares 6,458
Sale 24 Feb 2026
Value US$53,806.63 | Price 3.79 | Shares 14,197
Proposed sale 24 Feb 2026
Value US$53,852.06 | Price 3.79 | Shares 14,197
Sale 24 Feb 2026
Value US$17,598.36 | Price 3.77 | Shares 4,668
Proposed sale 24 Feb 2026
Value US$17,588.09 | Price 3.77 | Shares 4,668
Sale 24 Feb 2026
Value US$15,694.24 | Price 3.76 | Shares 4,174
Proposed sale 24 Feb 2026
Value US$15,710.94 | Price 3.76 | Shares 4,174
Sale 18 Feb 2026
Value US$13,354.08 | Price 3.44 | Shares 3,882
Proposed sale 18 Feb 2026
Value US$13,349.03 | Price 3.44 | Shares 3,882
Sale 18 Feb 2026
Value US$11,355.44 | Price 3.44 | Shares 3,301
Proposed sale 18 Feb 2026
Value US$11,345.54 | Price 3.44 | Shares 3,301
Sale 18 Feb 2026
Value US$40,006.12 | Price 3.41 | Shares 11,732
Proposed sale 18 Feb 2026
Value US$40,038.97 | Price 3.41 | Shares 11,732
Sale 10 Feb 2026
Value US$17,590.65 | Price 3.85 | Shares 4,569
Proposed sale 10 Feb 2026
Value US$17,598.87 | Price 3.85 | Shares 4,569
Sale 10 Feb 2026
Value US$13,571.25 | Price 3.85 | Shares 3,525
Proposed sale 10 Feb 2026
Value US$13,552.57 | Price 3.84 | Shares 3,525
Sale 10 Feb 2026
Value US$46,085.76 | Price 3.78 | Shares 12,192
Proposed sale 10 Feb 2026
Value US$46,093.08 | Price 3.78 | Shares 12,192
Sale 3 Oct 2025
Value US$36,643.48 | Price 4.78 | Shares 7,666
Proposed sale 3 Oct 2025
Value US$36,633.51 | Price 4.78 | Shares 7,666
Proposed sale 3 Oct 2025
Value US$27,936.55 | Price 4.78 | Shares 5,843
Sale 18 Aug 2025
Value US$70,870.00 | Price 3.73 | Shares 19,000
Proposed sale 18 Aug 2025
Value US$70,680.00 | Price 3.72 | Shares 19,000
Sale 2 Apr 2025
Value US$34,594.98 | Price 3.43 | Shares 10,086
Proposed sale 2 Apr 2025
Value US$34,624.23 | Price 3.43 | Shares 10,086
Sale 2 Apr 2025
Value US$37,335.55 | Price 3.43 | Shares 10,885
Proposed sale 2 Apr 2025
Value US$37,369.29 | Price 3.43 | Shares 10,885
Sale 20 Feb 2025
Value US$14,079.30 | Price 4.26 | Shares 3,305
Proposed sale 20 Feb 2025
Value US$14,075.00 | Price 4.26 | Shares 3,305
Sale 20 Feb 2025
Value US$49,616.48 | Price 4.24 | Shares 11,702
Proposed sale 20 Feb 2025
Value US$49,665.63 | Price 4.24 | Shares 11,702
Sale 20 Feb 2025
Value US$16,549.50 | Price 4.25 | Shares 3,894
Proposed sale 20 Feb 2025
Value US$16,556.90 | Price 4.25 | Shares 3,894
Sale 11 Feb 2025
Value US$30,927.50 | Price 4.45 | Shares 6,950
Proposed sale 11 Feb 2025
Value US$30,937.93 | Price 4.45 | Shares 6,950
Sale 11 Feb 2025
Value US$24,087.85 | Price 4.45 | Shares 5,413
Proposed sale 11 Feb 2025
Value US$24,109.50 | Price 4.45 | Shares 5,413
Planned sale 11 Feb 2025
Value US$74,065.80 | Price 4.45 | Shares 16,644
Proposed sale 11 Feb 2025
Value US$74,045.83 | Price 4.45 | Shares 16,644
Sale 11 Feb 2025
Value US$19,393.10 | Price 4.45 | Shares 4,358
Proposed sale 11 Feb 2025
Value US$19,412.28 | Price 4.45 | Shares 4,358
Sale 14 Jan 2025
Value US$6,109.83 | Price 5.13 | Shares 1,191
Proposed sale 14 Jan 2025
Value US$6,105.78 | Price 5.13 | Shares 1,191
Sale 14 Jan 2025
Value US$15,712.83 | Price 5.09 | Shares 3,087
Proposed sale 14 Jan 2025
Value US$15,721.47 | Price 5.09 | Shares 3,087
Planned sale 23 Dec 2024
Value US$36,725.00 | Price 5.65 | Shares 6,500
Proposed sale 23 Dec 2024
Value US$36,747.27 | Price 5.65 | Shares 6,500
Sale 2 Oct 2024
Value US$34,914.18 | Price 5.82 | Shares 5,999
Proposed sale 2 Oct 2024
Value US$34,920.18 | Price 5.82 | Shares 5,999
Sale 2 Apr 2024
Value US$119,453.90 | Price 9.86 | Shares 12,115
Proposed sale 2 Apr 2024
Value US$119,507.21 | Price 9.86 | Shares 12,115
Sale 2 Apr 2024
Value US$13,407.16 | Price 9.88 | Shares 1,357
Proposed sale 2 Apr 2024
Value US$13,413.54 | Price 9.88 | Shares 1,357
Sale 21 Feb 2024
Value US$97,226.18 | Price 7.46 | Shares 13,033
Proposed sale 21 Feb 2024
Value US$97,206.63 | Price 7.46 | Shares 13,033
Sale 21 Feb 2024
Value US$28,079.44 | Price 7.46 | Shares 3,764
Proposed sale 21 Feb 2024
Value US$28,075.68 | Price 7.46 | Shares 3,764
Sale 21 Feb 2024
Value US$25,136.55 | Price 7.47 | Shares 3,365
Proposed sale 21 Feb 2024
Value US$25,122.42 | Price 7.47 | Shares 3,365
Sale 21 Feb 2024
Value US$29,546.70 | Price 7.45 | Shares 3,966
Proposed sale 21 Feb 2024
Value US$29,557.41 | Price 7.45 | Shares 3,966
Sale 20 Feb 2024
Value US$4,623.36 | Price 7.68 | Shares 602
Proposed sale 20 Feb 2024
Value US$4,622.34 | Price 7.68 | Shares 602
Sale 17 Jan 2024
Value US$9,089.88 | Price 7.18 | Shares 1,266
Proposed sale 17 Jan 2024
Value US$9,088.23 | Price 7.18 | Shares 1,266
Planned sale 17 Jan 2024
Value US$18,182.45 | Price 7.15 | Shares 2,543
Proposed sale 17 Jan 2024
Value US$18,169.99 | Price 7.15 | Shares 2,543
Sale 3 Oct 2023
Value US$94,833.33 | Price 6.99 | Shares 13,567
Proposed sale 3 Oct 2023
Value US$94,784.49 | Price 6.99 | Shares 13,567
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-15 2026-05-15 PrS Proposed sale
2.8
Jorgensen Nathan D.

Former Officer

Officer
85,450
463.15
US$2,209,389 		85,450 463.15 US$2,209,389
2026-05-15 2026-05-15 PrS Proposed sale
2.8
Jorgensen Nathan D.

Former Officer

Officer
21,953
59.34
US$3,101,619 		21,953 59.34 US$3,101,619
2026-04-03 2026-04-02 S Sale
2.9
Sandrock Alfred

President and CEO

Executive Director
38,295 -46.2%
284.74
US$2,093,027 		38,295 -46.2% 284.74 US$2,093,027
2026-04-02 2026-04-02 PrS Proposed sale
2.9
Sandrock Alfred

Officer; Director

Executive Director
11,511
3.87
US$44,597 		11,511 3.87 US$44,597
2026-02-26 2026-02-24 S Sale
2.7
Swartz Robin

COO & CBO

Officer
6,458 -3.1%
3.77
US$24,347 		6,458 -3.1% 3.77 US$24,347
2026-02-26 2026-02-24 S Sale
2.9
Sandrock Alfred

President and CEO

Executive Director
14,197 -2.8%
3.79
US$53,807 		14,197 -2.8% 3.79 US$53,807
2026-02-26 2026-02-24 S Sale
2.8
Jorgensen Nathan D.

Chief Financial Officer

Officer
4,668 -3.0%
3.77
US$17,598 		4,668 -3.0% 3.77 US$17,598
2026-02-26 2026-02-24 S Sale
3.0
Carter Todd Alfred

Chief Scientific Officer

Officer
4,174 -2.8%
3.76
US$15,694 		4,174 -2.8% 3.76 US$15,694
2026-02-24 2026-02-24 PrS Proposed sale
3.0
Carter Todd Alfred

Officer

Officer
4,174
3.76
US$15,711 		4,174 3.76 US$15,711
2026-02-24 2026-02-24 PrS Proposed sale
2.8
Jorgensen Nathan D.

Officer

Officer
4,668
3.77
US$17,588 		4,668 3.77 US$17,588
2026-02-24 2026-02-24 PrS Proposed sale
2.7
Swartz Robin

Officer

Officer
6,458
3.77
US$24,335 		6,458 3.77 US$24,335
2026-02-24 2026-02-24 PrS Proposed sale
2.9
Sandrock Alfred

Officer; Director

Executive Director
14,197
3.79
US$53,852 		14,197 3.79 US$53,852
2026-02-20 2026-02-18 S Sale
2.7
Swartz Robin

COO & CBO

Officer
3,882 -1.8%
3.44
US$13,354 		3,882 -1.8% 3.44 US$13,354
2026-02-20 2026-02-18 S Sale
3.0
Carter Todd Alfred

Chief Scientific Officer

Officer
3,301 -2.2%
3.44
US$11,355 		3,301 -2.2% 3.44 US$11,355
2026-02-20 2026-02-18 S Sale
2.9
Sandrock Alfred

President and CEO

Executive Director
11,732 -2.3%
3.41
US$40,006 		11,732 -2.3% 3.41 US$40,006
2026-02-18 2026-02-18 PrS Proposed sale
2.9
Sandrock Alfred

Officer; Director

Executive Director
11,732
3.41
US$40,039 		11,732 3.41 US$40,039
2026-02-18 2026-02-18 PrS Proposed sale
3.0
Carter Todd Alfred

Officer

Officer
3,301
3.44
US$11,346 		3,301 3.44 US$11,346
2026-02-18 2026-02-18 PrS Proposed sale
2.7
Swartz Robin

Officer

Officer
3,882
3.44
US$13,349 		3,882 3.44 US$13,349
2026-02-11 2026-02-10 S Sale
2.7
Swartz Robin

COO & CBO

Officer
4,569 -2.1%
3.85
US$17,591 		4,569 -2.1% 3.85 US$17,591
2026-02-11 2026-02-10 S Sale
3.0
Carter Todd Alfred

Chief Scientific Officer

Officer
3,525 -2.2%
3.85
US$13,571 		3,525 -2.2% 3.85 US$13,571
2026-02-11 2026-02-10 S Sale
2.9
Sandrock Alfred

President and CEO

Executive Director
12,192 -2.3%
3.78
US$46,086 		12,192 -2.3% 3.78 US$46,086
2026-02-10 2026-02-10 PrS Proposed sale
2.9
Sandrock Alfred

Officer; Director

Executive Director
12,192
3.78
US$46,093 		12,192 3.78 US$46,093
2026-02-10 2026-02-10 PrS Proposed sale
2.7
Swartz Robin

Officer

Officer
4,569
3.85
US$17,599 		4,569 3.85 US$17,599
2026-02-10 2026-02-10 PrS Proposed sale
3.0
Carter Todd Alfred

Officer

Officer
3,525
3.84
US$13,553 		3,525 3.84 US$13,553
2025-10-07 2025-10-03 S Sale
2.8
Jorgensen Nathan D.

Chief Financial Officer

Officer
7,666 -5.8%
4.78
US$36,643 		7,666 -5.8% 4.78 US$36,643
2025-10-03 2025-10-03 PrS Proposed sale
2.8
Fahey Sandell Jacquelyn

Officer

Officer
5,843
4.78
US$27,937 		5,843 4.78 US$27,937
2025-10-03 2025-10-03 PrS Proposed sale
2.8
Jorgensen Nathan D.

Officer

Officer
7,666
4.78
US$36,634 		7,666 4.78 US$36,634
2025-08-20 2025-08-18 S Sale
1.6
Ferguson Toby

Chief Medical Officer

Officer
19,000 -12.0%
3.73
US$70,870 		19,000 -12.0% 3.73 US$70,870
2025-08-18 2025-08-18 PrS Proposed sale
1.6
Ferguson Toby

Officer

Officer
19,000
3.72
US$70,680 		19,000 3.72 US$70,680
2025-04-04 2025-04-02 S Sale
1.6
Ferguson Toby

Chief Medical Officer

Officer
10,086 -6.0%
3.43
US$34,595 		10,086 -6.0% 3.43 US$34,595
2025-04-04 2025-04-02 S Sale
2.9
Sandrock Alfred

President and CEO

Executive Director
10,885 -2.5%
3.43
US$37,336 		10,885 -2.5% 3.43 US$37,336
2025-04-02 2025-04-02 PrS Proposed sale
2.9
Sandrock Alfred

Officer; Director

Executive Director
10,885
3.43
US$37,369 		10,885 3.43 US$37,369
2025-04-02 2025-04-02 PrS Proposed sale
1.6
Ferguson Toby

Officer

Officer
10,086
3.43
US$34,624 		10,086 3.43 US$34,624
2025-02-24 2025-02-20 S Sale
3.0
Carter Todd Alfred

Chief Scientific Officer

Officer
3,305 -4.1%
4.26
US$14,079 		3,305 -4.1% 4.26 US$14,079
2025-02-24 2025-02-20 S Sale
2.9
Sandrock Alfred

President and CEO

Executive Director
11,702 -3.8%
4.24
US$49,616 		11,702 -3.8% 4.24 US$49,616
2025-02-24 2025-02-20 S Sale
2.7
Swartz Robin

COO & CBO

Officer
3,894 -3.8%
4.25
US$16,550 		3,894 -3.8% 4.25 US$16,550
2025-02-20 2025-02-20 PrS Proposed sale
2.9
Sandrock Alfred

Officer; Director

Executive Director
11,702
4.24
US$49,666 		11,702 4.24 US$49,666
2025-02-20 2025-02-20 PrS Proposed sale
3.0
Carter Todd Alfred

Officer

Officer
3,305
4.26
US$14,075 		3,305 4.26 US$14,075
2025-02-20 2025-02-20 PrS Proposed sale
2.7
Swartz Robin

Officer

Officer
3,894
4.25
US$16,557 		3,894 4.25 US$16,557
2025-02-12 2025-02-11 S Sale
2.7
Swartz Robin

COO & CBO

Officer
6,950 -6.4%
4.45
US$30,928 		6,950 -6.4% 4.45 US$30,928
2025-02-12 2025-02-11 S Sale
3.0
Carter Todd Alfred

Chief Scientific Officer

Officer
5,413 -6.3%
4.45
US$24,088 		5,413 -6.3% 4.45 US$24,088
2025-02-12 2025-02-11 PlS Planned sale
2.9
Sandrock Alfred

President & CEO

Officer
16,644 -5.1%
4.45
US$74,066 		16,644 -5.1% 4.45 US$74,066
2025-02-12 2025-02-11 S Sale
2.8
Fahey Sandell Jacquelyn

Chief Legal Officer

Officer
4,358 -5.1%
4.45
US$19,393 		4,358 -5.1% 4.45 US$19,393
2025-02-11 2025-02-11 PrS Proposed sale
2.8
Fahey Sandell Jacquelyn

Officer

Officer
4,358
4.45
US$19,412 		4,358 4.45 US$19,412
2025-02-11 2025-02-11 PrS Proposed sale
3.0
Carter Todd Alfred

Officer

Officer
5,413
4.45
US$24,110 		5,413 4.45 US$24,110
2025-02-11 2025-02-11 PrS Proposed sale
2.9
Sandrock Alfred

Officer; Director

Executive Director
16,644
4.45
US$74,046 		16,644 4.45 US$74,046
2025-02-11 2025-02-11 PrS Proposed sale
2.7
Swartz Robin

Officer

Officer
6,950
4.45
US$30,938 		6,950 4.45 US$30,938
2025-01-15 2025-01-14 S Sale
3.0
Carter Todd Alfred

Chief Scientific Officer

Officer
1,191 -1.4%
5.13
US$6,110 		1,191 -1.4% 5.13 US$6,110
2025-01-15 2025-01-14 S Sale
2.7
Swartz Robin

COO & CBO

Officer
3,087 -2.7%
5.09
US$15,713 		3,087 -2.7% 5.09 US$15,713
2025-01-14 2025-01-14 PrS Proposed sale
2.7
Swartz Robin

Officer

Officer
3,087
5.09
US$15,721 		3,087 5.09 US$15,721
2025-01-14 2025-01-14 PrS Proposed sale
3.0
Carter Todd Alfred

Officer

Officer
1,191
5.13
US$6,106 		1,191 5.13 US$6,106
2024-12-26 2024-12-23 PlS Planned sale
2.7
Swartz Robin

COO&CBO

Officer
6,500 -5.5%
5.65
US$36,725 		6,500 -5.5% 5.65 US$36,725
2024-12-23 2024-12-23 PrS Proposed sale
2.7
Swartz Robin

Officer

Officer
6,500
5.65
US$36,747 		6,500 5.65 US$36,747
2024-10-03 2024-10-02 S Sale
2.8
Fahey Sandell Jacquelyn

Chief Legal Officer

Officer
5,999 -6.5%
5.82
US$34,914 		5,999 -6.5% 5.82 US$34,914
2024-10-02 2024-10-02 PrS Proposed sale
2.8
Fahey Sandell Jacquelyn

Officer

Officer
5,999
5.82
US$34,920 		5,999 5.82 US$34,920
2024-04-03 2024-04-02 S Sale
2.9
Sandrock Alfred

President and CEO

Executive Director
12,115 -3.6%
9.86
US$119,454 		12,115 -3.6% 9.86 US$119,454
2024-04-03 2024-04-02 S Sale
2.7
Swartz Robin

Chief Operating Officer

Officer
1,357 -1.1%
9.88
US$13,407 		1,357 -1.1% 9.88 US$13,407
2024-04-02 2024-04-02 PrS Proposed sale
2.7
Swartz Robin

Officer

Officer
1,357
9.88
US$13,414 		1,357 9.88 US$13,414
2024-04-02 2024-04-02 PrS Proposed sale
2.9
Sandrock Alfred

Officer; Director

Executive Director
12,115
9.86
US$119,507 		12,115 9.86 US$119,507
2024-02-22 2024-02-21 S Sale
2.9
Sandrock Alfred

President and CEO

Executive Director
13,033 -3.7%
7.46
US$97,226 		13,033 -3.7% 7.46 US$97,226
2024-02-22 2024-02-21 S Sale
3.3
PFREUNDSCHUH PETER P.

Chief Financial Officer

Officer
3,764 -2.1%
7.46
US$28,079 		3,764 -2.1% 7.46 US$28,079
2024-02-22 2024-02-21 S Sale
3.0
Carter Todd Alfred

Chief Scientific Officer

Officer
3,365 -3.7%
7.47
US$25,137 		3,365 -3.7% 7.47 US$25,137
2024-02-22 2024-02-21 S Sale
2.7
Swartz Robin

Chief Operating Officer

Officer
3,966 -3.2%
7.45
US$29,547 		3,966 -3.2% 7.45 US$29,547
2024-02-21 2024-02-21 PrS Proposed sale
2.9
Sandrock Alfred

Officer; Director

Executive Director
13,033
7.46
US$97,207 		13,033 7.46 US$97,207
2024-02-21 2024-02-21 PrS Proposed sale
3.3
PFREUNDSCHUH PETER P.

Officer

Officer
3,764
7.46
US$28,076 		3,764 7.46 US$28,076
2024-02-21 2024-02-21 PrS Proposed sale
2.7
Swartz Robin

Officer

Officer
3,966
7.45
US$29,557 		3,966 7.45 US$29,557
2024-02-21 2024-02-21 PrS Proposed sale
3.0
Carter Todd Alfred

Officer

Officer
3,365
7.47
US$25,122 		3,365 7.47 US$25,122
2024-02-22 2024-02-20 S Sale
3.0
Carter Todd Alfred

Chief Scientific Officer

Officer
602 -0.7%
7.68
US$4,623 		602 -0.7% 7.68 US$4,623
2024-02-20 2024-02-20 PrS Proposed sale
3.0
Carter Todd Alfred

Officer

Officer
602
7.68
US$4,622 		602 7.68 US$4,622
2024-01-19 2024-01-17 S Sale
3.0
Carter Todd Alfred

Chief Scientific Officer

Officer
1,266 -2.3%
7.18
US$9,090 		1,266 -2.3% 7.18 US$9,090
2024-01-19 2024-01-17 PlS Planned sale
2.7
Swartz Robin

Chief Operating Officer

Officer
2,543 -3.4%
7.15
US$18,182 		2,543 -3.4% 7.15 US$18,182
2024-01-17 2024-01-17 PrS Proposed sale
2.7
Swartz Robin

Officer

Officer
2,543
7.15
US$18,170 		2,543 7.15 US$18,170
2024-01-17 2024-01-17 PrS Proposed sale
3.0
Carter Todd Alfred

Officer

Officer
1,266
7.18
US$9,088 		1,266 7.18 US$9,088
2023-10-05 2023-10-03 S Sale
3.3
PFREUNDSCHUH PETER P.

Chief Financial Officer

Officer
13,567 -8.3%
6.99
US$94,833 		13,567 -8.3% 6.99 US$94,833
2023-10-03 2023-10-03 PrS Proposed sale
3.3
PFREUNDSCHUH PETER P.

Officer

Officer
13,567
6.99
US$94,784 		13,567 6.99 US$94,784
Explore more

More insider trading research around Voyager Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America